Defining Research and Care in Diabetes in Pregnancy

妊娠期糖尿病研究和护理的定义

• 批准号: 10753647
• 负责人: SCOTT A SULLIVAN
• 金额: $ 1万
• 依托单位: INOVA HEALTH CARE SERVICES
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-15 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10753647
• 关键词: Address; Area; Basic Science; Caring; Church; Clinical; Clinical Sciences; Collaborations; Communities; Community Health Aides; Dedications; Diabetes Mellitus; Discipline of obstetrics; Disease; Endocrinologist; Epidemic; Faculty; Fostering; Future; Generations; Gestational Diabetes; Goals; Health; Health Professional; Hybrids; Individual; International; Location; Maternal-fetal medicine; Medical; Memory; Non-Insulin-Dependent Diabetes Mellitus; North America; Nurses; Oral; Outcome; Participant; Patients; Personal Satisfaction; Persons; Physicians; Policy Maker; Pregnancy in Diabetics; Pregnant Women; Prevention; Primary Care Physician; Public Health; Public Policy; Recording of previous events; Research; Research Personnel; Risk Factors; Scientist; Specialist; Students; Time; Translational Research; United States; cardiometabolism; career; clinical care; data dissemination; diabetes educator; driving force; falls; improved; innovation; interest; lectures; low and middle-income countries; meetings; novel; offspring; pregnant; profession allied to medicine; programs; social; social health determinants; symposium; tool; type I and type II diabetes; undergraduate student; virtual

PROJECT SUMMARY The 17th biennial meeting of the Diabetes in Pregnancy Study Group of North America (DPSG-NA) will be held on October 26-28, 2023 as a hybrid virtual and in-person meeting at the Physicians Conference Center at Inova Fairfax Medical Campus in Falls Church, VA. This 3-day research meeting focuses on pregnant individuals living with type 1, type 2, and gestational diabetes mellitus. Since its inception over 25 years ago, the DPSG-NA meetings have been a vehicle for the dissemination of data, gathered through collaboration among basic, translational, clinical, and public health researchers and practitioners both in the United States and abroad. The meeting covers a broad range of issues related to diabetes in pregnancy. The focus of the meeting is to highlight major, timely research areas to catalyze future discovery. The major goal of this meeting is, and has historically been, to serve as a driving force for discussions and new collaborations that open novel areas of exploration into prevention, treatment, and management approaches. These efforts are expected to reduce the burden of diabetes disease and its consequences for pregnant individuals and their offspring. The 17h biennial meeting has a strong emphasis on diversity, emphasizing the importance of social determinants of health and global perspectives, including low-and-middle-income countries. The meeting goals will be achieved through oral presentations, roundtable discussions, and debates that will bring together the world’s experts, young investigators, students, and trainees who have a committed interest to diabetes in pregnancy. The program includes 4 keynote addresses that each will be dedicated to a giant in the field of diabetes in pregnancy. The first keynote will be given in memory of Oded Langer by Roberto Romero, MD, DMed, Sci. Dr. Romero will speak on the prediction and prevention of obstetrical diseases. In addition, Cynthia Gyamfi-Bannerman, MD, MS will give the Elizabeth Thom Memorial Lecture where Dr. Gyamfi-Bannerman will speak of Dr. Thom’s contribution as the biostatistician of the MFMU network in changing clinical care in diabetes. Finally, Kevan Herold, MD will speak in the Lois Jovanovic Memorial Lecture and will address strategies to reduce the diabetes epidemic in the United States. Other speakers include established experts and young investigators, with about 20% of the meeting time allocated for speaker-conferee discussions. Young investigator presentations are an important aspect of the meeting, and they are an effective tool to help bring a new generation of scientists into our community and foster their maturation. Informal discussions among conferees are highlights of this unique meeting that fosters a collaborative, multifaceted approach to improving the health and wellbeing of pregnant women with diabetes and their offspring.

项目摘要 北美妊娠糖尿病研究组（DPSG-NA）第17届两年一度的会议将于 2023年10月26日至28日，在Inova的医生会议中心举行混合虚拟和面对面会议 弗吉尼亚州福尔斯教堂的费尔法克斯医学院。这个为期3天的研究会议的重点是怀孕的人生活 患有1型2型和妊娠期糖尿病自25年前成立以来，DPSG-NA 会议一直是传播数据的一种手段，这些数据是通过基础、 翻译，临床和公共卫生研究人员和从业人员在美国和国外。的 会议涵盖了与妊娠糖尿病有关的广泛问题。会议的重点是突出 重要的、及时的研究领域，以促进未来的发现。这次会议的主要目标是，并在历史上 作为讨论和新合作的推动力，开辟了新的探索领域， 预防、治疗和管理方法。预计这些努力将减轻 糖尿病及其对怀孕个体及其后代的后果。第17届双年度会议 非常强调多样性，强调健康和全球健康的社会决定因素的重要性。 包括低收入和中等收入国家。会议目标将通过口头 演讲，圆桌讨论和辩论，将汇集世界各地的专家，年轻的 对怀孕期间糖尿病感兴趣的研究人员、学生和学员。程序 包括4个主题演讲，每个主题演讲将致力于妊娠糖尿病领域的一个巨人。的 第一个主题演讲将由罗伯托·罗梅罗，医学博士，DMed，科学家在奥德兰格的记忆。罗梅罗医生会 关于产科疾病的预测和预防的发言。此外，Cynthia Gyamfi-Bannerman，MD， MS将给伊丽莎白·托姆纪念讲座，Gyamfi-Bannerman博士将谈到托姆博士的 作为MFMU网络的生物统计学家，她在改变糖尿病临床护理方面做出了贡献。最后，凯文 医学博士赫罗尔德将在洛伊斯·约万诺维奇纪念讲座上发言，并将讨论减少糖尿病的策略。 在美国流行。其他演讲者包括知名专家和年轻的研究人员， 20%的会议时间分配给演讲者与与会者的讨论。年轻的研究人员介绍是一个 会议的重要方面，他们是一个有效的工具，以帮助把新一代的科学家， 我们的社区，并促进他们的成熟。与会者之间的非正式讨论是这一独特的亮点 会议，促进合作，多方面的方法，以改善孕妇的健康和福祉， 患有糖尿病的妇女及其后代。